4-Iodobenzotrifluoride | CAS:455-13-0 99.0% bulk supply

We serve 4-Iodobenzotrifluoride CAS:455-13-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Synonyms：

4-Iodo-α,α,α-trifluorotoluene

1-Iodo-4-(trifluoromethyl)benzene

Molecular Formula: C7H4F3I

Molecular Weight: 272.00600

Appearance and properties: light brown liquid

Density: 1.851 g/mL at 25 °C(lit.)

Boiling point: 185-186 °C745 mm Hg(lit.)

Melting point: −8.33 °C(lit.)

Flash point: 156 °F

Refractive index: n20/D 1.516(lit.)

Stability: Stable at room temperature in closed containers under normal storage and handling conditions.

Storage conditions: Keep away from heat, sparks, and flame. Keep away from sources of ignition. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Items of Analysis	Standard of Analysis	Test Results
Appearance	Light brown liquid	Conform
Assay	≥98.0%	98.55%
Water	≤0.5%	0.22%
Conclusion	Conforms to Factory Standard

Contact us for information like 4-Iodobenzotrifluoride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Iodo-4-(trifluoromethyl)benzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Iodo-4-(trifluoromethyl)benzene Use and application,4-Iodo-α,α,α-trifluorotoluene technical grade,usp/ep/jp grade.

Related News: “Out of an abundance of caution and based on the latest advice from leading health experts, we’re closing all our corporate offices, stores and contact centers in mainland China through February 9.”5-Oxazolepropanal, 4-(4-chlorophenyl)-2-(2-methyl-1H-imidazol-1-yl)- manufacturer “Out of an abundance of caution and based on the latest advice from leading health experts, we’re closing all our corporate offices, stores and contact centers in mainland China through February 9.”9H-Xanthene-1-carboxylic acid,5,7-dichloro-2-[[2-[[(4-chlorophenyl)sulfonyl]amino]-2-oxoethyl]thio]-3,8-dihydroxy-6-methyl-9-oxo-, methyl ester supplier Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.2-(1-benzyl-4-hydroxy-1-oxy-piperidin-4-yl)-2-phenyl-acetamide vendor Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.